Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04713891
Title A Study of KF-0210 in Advanced Solid Tumors Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Keythera Pharmaceuticals (Australia) Pty Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.